Actinium Pharmaceuticals Cash Flow Statement (2010-2025) | ATNM

Cash Flow Statement Sep2010 Dec2010 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -0.01M0.01M0.00M-0.00M-1.32M-1.16M-2.72M-5.37M-5.08M-6.47M-8.05M-5.16M-7.85M-9.80M-11.29M-11.58M-15.18M-13.28M-9.32M-8.67M-11.35M-11.57M-15.94M-6.88M-5.13M-2.30M
Depreciation and Depletion (Quarter) 158.00159.00112.000.10M
Share-based Compensation (Quarter) 0.20M0.38M0.46M0.41M-1.23M0.42M0.42M0.97M0.98M0.99M1.00M0.92M0.93M1.38M1.37M1.34M8.87M5.10M
Gains from Sales and Divestitures (Quarter) 0.30M0.30M
Gains from Investment Securities (Quarter) 0.84M0.86M1.000.02M5.00120.000.00M0.00M0.00M0.15M5.000.00M14.000.01M0.01M4.90M0.00M0.04M0.00M
Non-cash Items (Quarter) 0.09M0.16M0.00M0.28M415.00473.005.38M0.01M0.00M1.13M0.00M0.37M12.54M10.46M0.00M152.000.30M0.00M0.05M
Cash from Operations (Quarter) -0.01M-0.00M-0.95M-5.64M-4.58M-5.59M-5.05M-5.78M27.92M-5.71M-7.78M-15.08M-13.64M-11.12M-7.49M-7.37M-7.97M-11.97M-7.57M2.74M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.22M0.23M0.23M
Amortization of Deferred Charges (Quarter) 0.07M0.07M0.07M
Depreciation & Amortization (CF) (Quarter) 158.00159.00112.000.12M0.13M0.13M0.14M0.14M0.18M0.22M0.16M0.18M0.21M0.20M-0.38M0.22M0.19M0.20M0.20M-0.43M
Change in Working Capital
Change in Receivables (Quarter) -0.05M-1.00
Change in Account Payables (Quarter) 0.00M0.00M-0.00M0.00M-0.00M0.00M
Change in Accured Expenses (Quarter) -0.00M-0.00M0.00M-0.16M-0.61M-0.30M0.35M1.76M-0.28M0.51M2.10M2.26M-2.77M1.28M-0.49M-0.20M-0.44M1.66M-1.98M-1.05M0.41M
Investing Activities
Capital Expenditures (Quarter) 0.00M0.00M0.06M0.07M0.01M0.27M0.07M0.02M0.08M0.05M0.03M0.01M0.09M
Cash from Investing Activities (Quarter) -0.03M-0.00M0.03M-0.00M-0.06M-0.07M-0.01M-0.27M-0.07M-0.02M-0.08M-0.05M-0.03M-0.01M-0.09M
Financing Activities
Other financing activities (Quarter) 0.38M0.46M0.41M0.45M0.42M0.42M0.97M0.98M0.99M1.00M0.92M0.93M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) -0.02M0.00M0.01M0.01M
Change in Capital Stock
Shares Issued (Quarter) 0.01M4.89M0.77M9.79M2.86M1.19M0.07M24.58M5.25M
Shares Repurchased (Quarter) 0.21M
Preferred Shares Issued (Quarter) 0.66M-1.00
Misc.
Cash from Financing Activities (Quarter) -0.02M0.00M0.66M14.34M14.30M5.78M0.80M-0.02M16.66M1.57M4.89M0.77M10.05M2.86M1.19M14.77M9.95M4.60M-0.00M-29.54M
Change in Cash (Quarter) -0.03M5.51M-0.29M8.69M9.66M0.12M-4.25M-5.81M44.31M-4.21M-2.90M-14.38M-3.64M-8.29M-6.30M7.38M1.98M-7.37M-7.58M-26.89M
Free Cash Flow (Quarter) -0.01M-0.00M-0.95M-5.65M-4.64M-5.66M-5.05M-5.79M27.65M-5.79M-7.79M-15.15M-13.69M-11.15M-7.49M-7.38M-7.97M-11.97M-7.57M2.65M
Net Cash Flow (Quarter) -0.03M-0.03M-0.29M0.03M8.69M9.66M0.12M-4.25M-5.81M44.31M-4.21M-2.90M-14.38M-3.64M-8.29M-6.30M7.38M1.98M-7.37M-7.58M-26.89M